Rio Grande Urology | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC	PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy	Recruiting	Phase 1 / Phase 2	2026-10-09		NCT07226986
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.	Oligometastatic Prostate Cancer (OMPC)	Recruiting	Phase 3	2026-09-22		NCT05939414
SpaceIT Hydrogel System for Perirectal Spacing	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Not applicable	2026-09-14		NCT06451614
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Phase 2	2026-09-11		NCT05849298
Optilume™ BPH Catheter System in Men With Symptomatic BPH	Eye Diseases, Hereditary, Genital Diseases, Male Urogenital Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Urogenital Diseases, benign prostatic hyperplasia, color vision disorder, cone dystrophy, eye disorder, male reproductive system disorder, nervous system disorder, prostate disorder, vision disorder	Active, not recruiting	Not applicable	2026-07-30		NCT04131907